Our Work

Representative Engagements

A selection of clinical programs where APEX Clinical delivered precision monitoring, regulatory expertise, and measurable outcomes.

Phase I

CAR T Cell Therapy

First-in-Human CAR T Monitoring Program

Provided end-to-end monitoring for a first-in-human CAR T cell therapy trial, ensuring protocol adherence and data integrity across multiple US sites.

Zero critical findings at FDA inspection

On-schedule enrollment across 4 sites

Inspection-grade data package delivered

Phase II

Lipid Nanoparticles

LNP Delivery Platform — Multi-Center US/Canada Trial

Orchestrated monitoring and project management for a multi-center LNP-based therapeutic trial spanning US and Canadian sites with unified quality standards.

Seamless cross-border regulatory alignment

Canadian data accepted by FDA without amendment

Trial completed 3 weeks ahead of schedule

Phase I/II

Medical Device

West Coast Biotech — Early Phase Device Study

Supported a Nevada-based medical device company through site selection, initiation, and ongoing monitoring for an early-phase safety and efficacy study.

4 sites qualified and initiated in 6 weeks

Protocol deviation rate below 1%

Full CSR delivered on time

Engagements above are representative examples. Client names and proprietary details are withheld to protect confidentiality. Contact us to discuss your specific program requirements.

Ready to discuss your program?

Our team is available to review your trial requirements and outline how APEX Clinical can support your goals.